acc2651 |
ATM |
phosphorylation |
Ser1981 |
human |
Cancer |
CAOV3 |
Irofulven |
Associated |
4.0 (Moderate) |
15269203
|
acc2652 |
Chk2 |
phosphorylation |
Thr68 |
human |
Cancer |
A2780 |
Irofulven |
Associated |
4.0 (Moderate) |
15269203
|
acc2653 |
Chk2 |
phosphorylation |
Thr68 |
human |
Cancer |
A2780/CP70 |
Irofulven |
Associated |
4.0 (Moderate) |
15269203
|
acc2654 |
Chk2 |
phosphorylation |
Thr68 |
human |
Cancer |
CAOV3 |
Irofulven |
Associated |
4.0 (Moderate) |
15269203
|
acc2655 |
Chk2 |
phosphorylation |
Thr68 |
human |
Cancer |
OVCAR3 |
Irofulven |
Associated |
4.0 (Moderate) |
15269203
|
acc2656 |
Chk2 |
phosphorylation |
Thr68 |
human |
Cancer |
SKOV3 |
Irofulven |
Associated |
4.0 (Moderate) |
15269203
|
acc2657 |
NBS1 |
phosphorylation |
Ser343 |
human |
Cancer |
SKOV3 |
Irofulven |
Associated |
4.0 (Moderate) |
15269203
|
acc2658 |
NBS1 |
phosphorylation |
Ser343 |
human |
Cancer |
OVCAR3 |
Irofulven |
Associated |
4.0 (Moderate) |
15269203
|
acc2659 |
p53 |
phosphorylation |
Ser15 |
human |
Cancer |
A2780 |
Irofulven |
Associated |
4.0 (Moderate) |
15269203
|
acc2660 |
p53 |
phosphorylation |
Ser20 |
human |
Cancer |
A2780 |
Irofulven |
Associated |
4.0 (Moderate) |
15269203
|
acc2661 |
SMC1 |
phosphorylation |
Ser957 |
human |
Cancer |
CAOV3 |
Irofulven |
Associated |
4.0 (Moderate) |
15269203
|
acc2662 |
SMC1 |
phosphorylation |
Ser957 |
human |
Cancer |
SKOV3 |
Irofulven |
Associated |
4.0 (Moderate) |
15269203
|
acc2663 |
SMC1 |
phosphorylation |
Ser957 |
human |
Cancer |
OVCAR3 |
Irofulven |
Associated |
4.0 (Moderate) |
15269203
|
acc2664 |
AKT |
phosphorylation |
Ser473 |
human |
Breast Cancer |
MDA-MB-231 |
Ganoderma lucidum |
Associated |
4.0 (Moderate) |
15489214
|
acc2665 |
AKT |
phosphorylation |
Thr308 |
human |
Gastric Cancer |
MKN-45 |
CH-11 |
Impairing |
5.0 (High)
|
15767780
|
acc2666 |
histone H3 |
acetylation |
unclear |
human |
Hepatocellular Carcinoma |
HepG2 |
TSA |
Associated |
3.0 (Low)
|
15955204
|
acc2667 |
histone H3 |
acetylation |
unclear |
human |
Hepatocellular Carcinoma |
Huh-7 |
TSA |
Associated |
3.0 (Low)
|
15955204
|
acc2668 |
histone H4 |
acetylation |
unclear |
human |
Hepatocellular Carcinoma |
HepG2 |
TSA |
Associated |
3.0 (Low)
|
15955204
|
acc2669 |
histone H4 |
acetylation |
unclear |
human |
Hepatocellular Carcinoma |
Huh-7 |
TSA |
Associated |
3.0 (Low)
|
15955204
|
acc2670 |
AKT |
phosphorylation |
Ser473 |
human |
Breast Cancer |
MDA-MB-231 |
EPA + DHA |
Associated |
4.0 (Moderate) |
15986129
|
acc2671 |
AKT |
phosphorylation |
Ser473 |
human |
Lung Cancer |
A549 |
Rapamycin |
Impairing |
5.0 (High)
|
16103051
|
acc2672 |
AKT |
phosphorylation |
Ser473 |
human |
Lung Cancer |
H157 |
Rapamycin |
Impairing |
5.0 (High)
|
16103051
|
acc2673 |
AKT |
phosphorylation |
Ser473 |
human |
Lung Cancer |
H358 |
Rapamycin |
Impairing |
5.0 (High)
|
16103051
|
acc2674 |
AKT |
phosphorylation |
Ser473 |
human |
Lung Cancer |
H460 |
Rapamycin |
Impairing |
5.0 (High)
|
16103051
|
acc2675 |
eIF4E |
phosphorylation |
Ser209 |
human |
Lung Cancer |
A549 |
Rapamycin |
Impairing |
5.0 (High)
|
16103051
|
acc2676 |
eIF4E |
phosphorylation |
Ser209 |
human |
Lung Cancer |
H157 |
Rapamycin |
Impairing |
5.0 (High)
|
16103051
|
acc2677 |
eIF4E |
phosphorylation |
Ser209 |
human |
Lung Cancer |
H358 |
Rapamycin |
Impairing |
5.0 (High)
|
16103051
|
acc2678 |
eIF4E |
phosphorylation |
Ser209 |
human |
Lung Cancer |
H460 |
Rapamycin |
Impairing |
5.0 (High)
|
16103051
|
acc2679 |
ACC |
phosphorylation |
Ser79 |
human |
Cancer |
"MCF-7,T98G,U87MG,PC-3,K-562,CEM T" |
AICAR |
Associated |
4.0 (Moderate) |
16176927
|
acc2680 |
ACC |
phosphorylation |
Ser79 |
rat |
Glioma |
C6 |
AICAR |
Associated |
4.0 (Moderate) |
16176927
|
acc2681 |
AKT |
phosphorylation |
Ser473 |
human |
Cancer |
"MCF-7,T98G,U87MG,K-562,CEM T" |
AICAR |
Associated |
4.0 (Moderate) |
16176927
|
acc2682 |
Akt |
phosphorylation |
Ser473 |
rat |
Glioma |
C6 |
AICAR |
Associated |
4.0 (Moderate) |
16176927
|
acc2683 |
AMPK |
phosphorylation |
Thr172 |
human |
Cancer |
"MCF-7,T98G,U87MG,K-562,CEM T" |
AICAR |
Associated |
4.0 (Moderate) |
16176927
|
acc2684 |
AMPK |
phosphorylation |
Thr172 |
rat |
Glioma |
C6 |
AICAR |
Associated |
4.0 (Moderate) |
16176927
|
acc2685 |
AMPK |
phosphorylation |
Thr183 |
rat |
Glioma |
C6 |
AICAR |
Associated |
4.0 (Moderate) |
16176927
|
acc2686 |
mTOR |
phosphorylation |
Ser1448 |
human |
Cancer |
"MCF-7,T98G,U87MG,K-562,CEM T" |
AICAR |
Associated |
4.0 (Moderate) |
16176927
|
acc2687 |
mTOR |
phosphorylation |
Ser1448 |
rat |
Glioma |
C6 |
AICAR |
Associated |
4.0 (Moderate) |
16176927
|
acc2688 |
Wwox |
phosphorylation |
Tyr287 |
human |
Prostate Cancer |
LNCaP |
Geldanamycin |
Associated |
4.0 (Moderate) |
16288044
|
acc2689 |
DARPP-32 |
phosphorylation |
Thr34 |
rat |
Cell Signaling |
PC-12/rNPFF1 |
PFR(Tic)amide + Forskolin |
Associated |
2.0 (Low)
|
16490283
|
acc2690 |
eIF2alpha |
phosphorylation |
Ser51 |
mouse |
Apoptosis |
|
TNFalpha |
Associated |
4.0 (Moderate) |
16717090
|
acc2691 |
IkappaBalpha |
phosphorylation |
Ser180 |
human |
Leukemia |
KBM–5 |
TNF |
Impairing |
4.5 (High)
|
16785236
|
acc2692 |
IKKbeta |
phosphorylation |
Ser181 |
human |
Leukemia |
KBM–5 |
TNF |
Impairing |
4.5 (High)
|
16785236
|
acc2693 |
IkappaBalpha |
phosphorylation |
Ser32 |
human |
Leukemia |
KBM–5 |
TNF |
Impairing |
4.5 (High)
|
16785236
|
acc2694 |
p65 |
phosphorylation |
Ser536 |
human |
Leukemia |
KBM–5 |
TNF |
Impairing |
4.5 (High)
|
16785236
|
acc2695 |
Akt |
phosphorylation |
unclear |
rat |
Atherosclerosis |
|
NQ304 |
Associated |
4.0 (Moderate) |
16875883
|
acc2696 |
ERK1 |
phosphorylation |
unclear |
rat |
Atherosclerosis |
|
NQ304 |
Associated |
4.0 (Moderate) |
16875883
|
acc2697 |
ERK2 |
phosphorylation |
unclear |
rat |
Atherosclerosis |
|
NQ304 |
Associated |
4.0 (Moderate) |
16875883
|
acc2698 |
eIF2alpha |
phosphorylation |
Ser51 |
human |
HCV |
HeLa |
H2O2 |
Associated |
4.0 (Moderate) |
17030858
|
acc2699 |
JNK |
phosphorylation |
Thr183 |
human |
Lung Cancer |
H1299 |
RASSF1A |
Associated |
4.0 (Moderate) |
17088994
|
acc2700 |
JNK |
phosphorylation |
Tyr185 |
human |
Lung Cancer |
H1299 |
RASSF1A |
Associated |
4.0 (Moderate) |
17088994
|